Identification and characterization of VEGF-A-responsive neutrophils expressing CD49d, VEGFR1, and CXCR4 in mice and humans.

Vascular endothelial growth factor A (VEGF-A) is upregulated during hypoxia and is the major regulator of angiogenesis. VEGF-A expression has also been found to recruit myeloid cells to ischemic tissues where they contribute to angiogenesis. This study investigates the mechanisms underlying neutrophil recruitment to VEGF-A as well as the characteristics of these neutrophils. A previously undefined circulating subset of neutrophils shown to be CD49d(+)VEGFR1(high)CXCR4(high) was identified in mice and humans. By using chimeric mice with impaired VEGF receptor 1 (VEGFR1) or VEGFR2 signaling (Flt-1tk(-/-), tsad(-/-)), we found that parallel activation of VEGFR1 on neutrophils and VEGFR2 on endothelial cells was required for VEGF-A-induced recruitment of circulating neutrophils to tissue. Intravital microscopy of mouse microcirculation revealed that neutrophil recruitment by VEGF-A versus by the chemokine macrophage inflammatory protein 2 (MIP-2 [CXCL2]) involved the same steps of the recruitment cascade but that an additional neutrophil integrin (eg, VLA-4 [CD49d/CD29]) played a crucial role in neutrophil crawling and emigration to VEGF-A. Isolated CD49d(+) neutrophils featured increased chemokinesis but not chemotaxis compared with CD49d(-) neutrophils in the presence of VEGF-A. Finally, by targeting the integrin α4 subunit (CD49d) in a transplantation-based angiogenesis model that used avascular pancreatic islets transplanted to striated muscle, we demonstrated that inhibiting the recruitment of circulating proangiogenic neutrophils to hypoxic tissue impairs vessel neoformation. Thus, angiogenesis can be modulated by targeting cell-surface receptors specifically involved in VEGF-A-dependent recruitment of proangiogenic neutrophils without compromising recruitment of the neutrophil population involved in the immune response to pathogens.

[1]  K. Alitalo,et al.  Vascular endothelial growth factor-B in physiology and disease. , 2014, Physiological reviews.

[2]  Steffen Jung,et al.  On-site education of VEGF-recruited monocytes improves their performance as angiogenic and arteriogenic accessory cells , 2013, The Journal of experimental medicine.

[3]  K. Alitalo,et al.  The Basis for the Distinct Biological Activities of Vascular Endothelial Growth Factor Receptor–1 Ligands , 2013, Science Signaling.

[4]  G. Opdenakker,et al.  VEGF-A recruits a proangiogenic MMP-9-delivering neutrophil subset that induces angiogenesis in transplanted hypoxic tissue. , 2012, Blood.

[5]  S. Kutschera,et al.  VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd , 2012, The Journal of experimental medicine.

[6]  R. Muschel,et al.  On the dual roles and polarized phenotypes of neutrophils in tumor development and progression. , 2012, Critical reviews in oncology/hematology.

[7]  Douglas Hanahan,et al.  Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment Prospects and Obstacles for Therapeutic Targeting of Function-enabling Stromal Cell Types , 2022 .

[8]  P. Kubes,et al.  The neutrophil in vascular inflammation , 2011, Nature Medicine.

[9]  P. Foubert,et al.  Receptor tyrosine kinases and TLR/IL1Rs unexpectedly activate myeloid cell PI3kγ, a single convergent point promoting tumor inflammation and progression. , 2011, Cancer cell.

[10]  Peter Carmeliet,et al.  Hypoxia and inflammation. , 2011, The New England journal of medicine.

[11]  J. Alexander,et al.  VEGF₁₆₄ differentially regulates neutrophil and T cell adhesion through ItgaL- and ItgaM-dependent mechanisms. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[12]  C. Rolny,et al.  A chemotactic gradient sequestered on endothelial heparan sulfate induces directional intraluminal crawling of neutrophils. , 2010, Blood.

[13]  C. Rolny,et al.  Clinical and Experimental Pancreatic Islet Transplantation to Striated Muscle , 2010, Diabetes.

[14]  Laura A. Sullivan,et al.  The VEGF family in cancer and antibody-based strategies for their inhibition , 2010, mAbs.

[15]  Hubing Shi,et al.  Overexpression of platelet-derived growth factor-BB increases tumor pericyte content via stromal-derived factor-1alpha/CXCR4 axis. , 2009, Cancer research.

[16]  K. Alitalo,et al.  VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. , 2009, Current opinion in cell biology.

[17]  Christian Fischer,et al.  FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? , 2008, Nature Reviews Cancer.

[18]  N. Ferrara,et al.  Role of myeloid cells in tumor angiogenesis and growth. , 2008, Trends in cell biology.

[19]  B. Heit,et al.  PTEN functions to 'prioritize' chemotactic cues and prevent 'distraction' in migrating neutrophils , 2008, Nature Immunology.

[20]  Jonas Jarvius,et al.  Endothelial Cell Migration in Stable Gradients of Vascular Endothelial Growth Factor A and Fibroblast Growth Factor 2 , 2008, Journal of Biological Chemistry.

[21]  Graciela Andonegui,et al.  Exogenous stromal cell-derived factor-1 induces modest leukocyte recruitment in vivo. , 2008, American journal of physiology. Heart and circulatory physiology.

[22]  P. Libby,et al.  The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions , 2007, The Journal of experimental medicine.

[23]  M. Cybulsky,et al.  Getting to the site of inflammation: the leukocyte adhesion cascade updated , 2007, Nature Reviews Immunology.

[24]  Bryan Heit,et al.  Intraluminal crawling of neutrophils to emigration sites: a molecularly distinct process from adhesion in the recruitment cascade , 2006, The Journal of experimental medicine.

[25]  A. King,et al.  No differences in efficacy between noncultured and cultured islets in reducing hyperglycemia in a nonvascularized islet graft model. , 2006, Diabetes Technology & Therapeutics.

[26]  M. Shibuya Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. , 2006, Journal of biochemistry and molecular biology.

[27]  P. Allavena,et al.  Role of tumor-associated macrophages in tumor progression and invasion , 2006, Cancer and Metastasis Reviews.

[28]  Masatomo Kobayashi,et al.  Drosophila IKK-Related Kinase Regulates Nonapoptotic Function of Caspases via Degradation of IAPs , 2006, Cell.

[29]  Christopher Chiu,et al.  Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis , 2006, Proceedings of the National Academy of Sciences.

[30]  A. Issekutz,et al.  Endothelial growth factors VEGF and bFGF differentially enhance monocyte and neutrophil recruitment to inflammation , 2006, Journal of leukocyte biology.

[31]  J. Alexander,et al.  VEGF-A stimulation of leukocyte adhesion to colonic microvascular endothelium: implications for inflammatory bowel disease. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[32]  Lena Claesson-Welsh,et al.  Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. , 2006, Experimental cell research.

[33]  F. Binet,et al.  Arsenic trioxide (AT) is a novel human neutrophil pro‐apoptotic agent: effects of catalase on AT‐induced apoptosis, degradation of cytoskeletal proteins and de novo protein synthesis , 2006, British journal of haematology.

[34]  Rinat Abramovitch,et al.  VEGF-Induced Adult Neovascularization: Recruitment, Retention, and Role of Accessory Cells , 2006, Cell.

[35]  T. Mustelin,et al.  The C terminus of T cell‐specific adapter protein (TSAd) is necessary for TSAd‐mediated inhibition of Lck activity , 2005, European Journal of Immunology.

[36]  Geoffrey C Gurtner,et al.  Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 , 2004, Nature Medicine.

[37]  C. Feistritzer,et al.  Expression and function of the vascular endothelial growth factor receptor FLT-1 in human eosinophils. , 2004, American journal of respiratory cell and molecular biology.

[38]  P. Ratcliffe,et al.  Regulation of angiogenesis by hypoxia: role of the HIF system , 2003, Nature Medicine.

[39]  Hong Zhang,et al.  Growth factor regulation of neutrophil‐endothelial cell interactions , 2001, Journal of leukocyte biology.

[40]  Hyung Jin Kim,et al.  Vascular Endothelial Growth Factor Expression of Intercellular Adhesion Molecule 1 (ICAM-1), Vascular Cell Adhesion Molecule 1 (VCAM-1), and E-selectin through Nuclear Factor-κB Activation in Endothelial Cells* , 2001, The Journal of Biological Chemistry.

[41]  D. Kimmig,et al.  The CC chemokine receptor 3 CCR3 is functionally expressed on eosinophils but not on neutrophils , 2000, European journal of immunology.

[42]  J. Bluestone,et al.  Ribp, a Novel Rlk/Txk- and Itk-Binding Adaptor Protein That Regulates T Cell Activation , 1999, The Journal of experimental medicine.

[43]  T. Noda,et al.  Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[44]  P. Kubes The role of shear forces in ischemia/reperfusion‐induced neutrophil rolling and adhesion , 1997, Journal of leukocyte biology.

[45]  A. Mantovani,et al.  Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. , 1996, Blood.

[46]  F. Lund-Johansen,et al.  Differential surface expression of cell adhesion molecules during granulocyte maturation , 1993, Journal of leukocyte biology.

[47]  H Ueno,et al.  The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. , 1992, Science.

[48]  H. Dvorak,et al.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.